Self-carried nanodrug (SCND-SIS3): A targeted therapy for lung cancer with superior biocompatibility and immune boosting effects-Reference-Cited by-同舟云学术

Self-carried nanodrug (SCND-SIS3): A targeted therapy for lung cancer with superior biocompatibility and immune boosting effects

Published:2022-09 Issue: Volume:288 Page:121730
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Lian Guang-Yu,Wan Yingpeng^ORCID,Mak Thomas Shiu-Kwong,Wang Qing-Ming,Zhang Jinfeng^ORCID,Chen Jiaoyi^ORCID,Wang Zi-Ying,Li Min,Tang Patrick Ming-Kuen,Huang Xiao-Ru,Lee Chun-Sing,Yu Xue-Qing,Lan Hui-Yao^ORCID

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference59 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA;Sung;A Cancer Journal for Clinicians,2021

2. Cancer Fact Sheets, Lung Cancer,2020

3. Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer;Chaft;Nat. Rev. Clin. Oncol.,2021

4. Cancer invasion and resistance: interconnected processes of disease progression and therapy failure;Alexander;Trends Mol. Med.,2012

5. Systemic therapy for locally advanced and metastatic non–small cell lung cancer: a review;Arbour;JAMA,2019

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression;Acta Pharmaceutica Sinica B;2024-09

2. Lung metastasis-Harnessed in-Situ adherent porous organic nanosponge-mediated antigen capture for A self-cascaded detained dendritic cells and T cell infiltration;Biomaterials;2024-03

3. Ionic Liquids Nanoliposomes Based on Targeted and Active Permeability for Enhanced Combination Chemotherapy Efficiency;Nano;2024-01-29

4. Metabolic adaptation of NK cell activity and behavior in tumors: challenges and therapeutic opportunities;Trends in Pharmacological Sciences;2023-11

5. SETD2 deficiency promotes renal fibrosis through the TGF‐β/Smad signalling pathway in the absence of VHL;Clinical and Translational Medicine;2023-11